SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Navidea Biopharmaceuticals, Inc. – ‘10-K’ for 12/31/20 – ‘EX-101.SCH’

On:  Friday, 3/26/21, at 5:01pm ET   ·   For:  12/31/20   ·   Accession #:  1437749-21-7329   ·   File #:  1-35076

Previous ‘10-K’:  ‘10-K’ on 3/18/20 for 12/31/19   ·   Next:  ‘10-K’ on 3/28/22 for 12/31/21   ·   Latest:  ‘10-K’ on 3/27/23 for 12/31/22   ·   36 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/26/21  Navidea Biopharmaceuticals, Inc.  10-K       12/31/20   93:9.8M                                   RDG Filings/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.23M 
 2: EX-21.1     Subsidiaries List                                   HTML     26K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     25K 
 4: EX-24.1     Power of Attorney                                   HTML     30K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
13: R1          Document And Entity Information                     HTML     64K 
14: R2          Consolidated Balance Sheets                         HTML    135K 
15: R3          Consolidated Balance Sheets (Parentheticals)        HTML     46K 
16: R4          Consolidated Statements of Operations               HTML    115K 
17: R5          Consolidated Statements of Comprehensive Loss       HTML     38K 
18: R6          Consolidated Statements of Stockholders' Equity     HTML    194K 
                (Deficit)                                                        
19: R7          Consolidated Statements of Stockholders' Equity     HTML     26K 
                (Deficit) (Parentheticals)                                       
20: R8          Consolidated Statements of Cash Flows               HTML    112K 
21: R9          Note 1 - Organization and Summary of Significant    HTML     99K 
                Accounting Policies                                              
22: R10         Note 2 - Liquidity                                  HTML     50K 
23: R11         Note 3 - Revenue From Contracts With Customers      HTML     73K 
24: R12         Note 4 - Stock-based Compensation                   HTML     60K 
25: R13         Note 5 - Loss Per Share                             HTML     31K 
26: R14         Note 6 - Stock Subscriptions and Other Receivables  HTML     38K 
                and Concentrations of Credit Risk                                
27: R15         Note 7 - Inventory                                  HTML     32K 
28: R16         Note 8 - Property and Equipment                     HTML     43K 
29: R17         Note 9 - Investment in Macrophage Therapeutics,     HTML     53K 
                Inc.                                                             
30: R18         Note 10 - Accounts Payable, Accrued Liabilities     HTML     36K 
                and Other                                                        
31: R19         Note 11 - Notes Payable                             HTML     37K 
32: R20         Note 12 - Leases                                    HTML     60K 
33: R21         Note 13 - Commitments and Contingencies             HTML     66K 
34: R22         Note 14 - Equity Instruments                        HTML     72K 
35: R23         Note 15 - Income Taxes                              HTML    119K 
36: R24         Note 16 - Segments                                  HTML    120K 
37: R25         Note 17 - Material Agreements                       HTML     36K 
38: R26         Note 18 - Employee Benefit Plan                     HTML     29K 
39: R27         Note 19 - Supplemental Disclosure for Statements    HTML     33K 
                of Cash Flows                                                    
40: R28         Note 20 - Subsequent Events                         HTML     33K 
41: R29         Significant Accounting Policies (Policies)          HTML    167K 
42: R30         Note 1 - Organization and Summary of Significant    HTML     40K 
                Accounting Policies (Tables)                                     
43: R31         Note 3 - Revenue From Contracts With Customers      HTML     50K 
                (Tables)                                                         
44: R32         Note 4 - Stock-based Compensation (Tables)          HTML     57K 
45: R33         Note 6 - Stock Subscriptions and Other Receivables  HTML     35K 
                and Concentrations of Credit Risk (Tables)                       
46: R34         Note 7 - Inventory (Tables)                         HTML     31K 
47: R35         Note 8 - Property and Equipment (Tables)            HTML     40K 
48: R36         Note 10 - Accounts Payable, Accrued Liabilities     HTML     33K 
                and Other (Tables)                                               
49: R37         Note 12 - Leases (Tables)                           HTML     61K 
50: R38         Note 14 - Equity Instruments (Tables)               HTML     39K 
51: R39         Note 15 - Income Taxes (Tables)                     HTML    108K 
52: R40         Note 16 - Segments (Tables)                         HTML    110K 
53: R41         Note 1 - Organization and Summary of Significant    HTML     97K 
                Accounting Policies (Details Textual)                            
54: R42         Note 1 - Organization and Summary of Significant    HTML     50K 
                Accounting Policies - Assumptions Used to                        
                Calculate Fair Value of Stock Option Awards                      
                Granted (Details)                                                
55: R43         Note 2 - Liquidity (Details Textual)                HTML    163K 
56: R44         Note 3 - Revenue From Contracts With Customers      HTML     50K 
                (Details Textual)                                                
57: R45         Note 3 - Revenue From Contracts With Customers -    HTML     42K 
                Disaggregation of Revenue (Details)                              
58: R46         Note 3 - Revenue From Contracts With Customers -    HTML     33K 
                Changes in Contract Liabilities (Details)                        
59: R47         Note 4 - Stock-based Compensation (Details          HTML     52K 
                Textual)                                                         
60: R48         Note 4 - Stock-based Compensation - Summary of      HTML     57K 
                Stock Option Activity (Details)                                  
61: R49         Note 4 - Stock-based Compensation - Summary of      HTML     41K 
                Unvested Restricted Stock (Details)                              
62: R50         Note 5 - Loss Per Share (Details Textual)           HTML     30K 
63: R51         Note 6 - Stock Subscriptions and Other Receivables  HTML     33K 
                and Concentrations of Credit Risk (Details                       
                Textual)                                                         
64: R52         Note 6 - Stock Subscriptions and Other Receivables  HTML     33K 
                and Concentrations of Credit Risk - Accounts and                 
                Other Receivables (Details)                                      
65: R53         Note 7 - Inventory (Details Textual)                HTML     31K 
66: R54         Note 7 - Inventory - Net Inventory (Details)        HTML     30K 
67: R55         Note 8 - Property and Equipment (Details Textual)   HTML     26K 
68: R56         Note 8 - Property and Equipment - Summary of Major  HTML     45K 
                Classes of Property and Equipment (Details)                      
69: R57         Note 9 - Investment in Macrophage Therapeutics,     HTML    106K 
                Inc. (Details Textual)                                           
70: R58         Note 10 - Accounts Payable, Accrued Liabilities     HTML     31K 
                and Other (Details Textual)                                      
71: R59         Note 10 - Accounts Payable, Accrued Liabilities     HTML     32K 
                and Other - Accrued Liabilities and Other                        
                (Details)                                                        
72: R60         Note 11 - Notes Payable (Details Textual)           HTML     57K 
73: R61         Note 12 - Leases (Details Textual)                  HTML     51K 
74: R62         Note 12 - Leases - Impact of the Adoption of ASU    HTML     39K 
                2016-02 on Our Balance Sheet (Details)                           
75: R63         Note 12 - Leases - Maturity of Lease Liabilities    HTML     39K 
                (Details)                                                        
76: R64         Note 12 - Leases - Balance Sheet Classification     HTML     34K 
                (Details)                                                        
77: R65         Note 12 - Leases - Other Information (Details)      HTML     28K 
78: R66         Note 13 - Commitments and Contingencies (Details    HTML     98K 
                Textual)                                                         
79: R67         Note 14 - Equity Instruments (Details Textual)      HTML    282K 
80: R68         Note 14 - Equity Instruments - Outstanding          HTML     42K 
                Warrants (Details)                                               
81: R69         Note 15 - Income Taxes (Details Textual)            HTML     55K 
82: R70         Note 15 - Income Taxes - Components of Deferred     HTML     47K 
                Tax Assets (Details)                                             
83: R71         Note 15 - Income Taxes - Net Operating Loss and     HTML     97K 
                Credit Carryforwards (Details)                                   
84: R72         Note 15 - Income Taxes - Reconciliations Between    HTML     47K 
                the Statutory Federal Income Tax Rate and the                    
                Effective Tax Rate (Details)                                     
85: R73         Note 16 - Segments (Details Textual)                HTML     38K 
86: R74         Note 16 - Segments - Segment Information (Details)  HTML    119K 
87: R75         Note 17 - Material Agreements (Details Textual)     HTML     56K 
88: R76         Note 18 - Employee Benefit Plan (Details Textual)   HTML     25K 
89: R77         Note 19 - Supplemental Disclosure for Statements    HTML     83K 
                of Cash Flows (Details Textual)                                  
90: R78         Note 20 - Subsequent Events (Details Textual)       HTML     64K 
92: XML         IDEA XML File -- Filing Summary                      XML    175K 
91: EXCEL       IDEA Workbook of Financial Reports                  XLSX    110K 
 7: EX-101.INS  XBRL Instance -- navb-20201231                       XML   2.61M 
 9: EX-101.CAL  XBRL Calculations -- navb-20201231_cal               XML    147K 
10: EX-101.DEF  XBRL Definitions -- navb-20201231_def                XML   2.12M 
11: EX-101.LAB  XBRL Labels -- navb-20201231_lab                     XML   1.44M 
12: EX-101.PRE  XBRL Presentations -- navb-20201231_pre              XML   2.09M 
 8: EX-101.SCH  XBRL Schema -- navb-20201231                         XSD    271K 
93: ZIP         XBRL Zipped Folder -- 0001437749-21-007329-xbrl      Zip    254K

‘EX-101.SCH’   —   XBRL Schema — navb-20201231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Generated by ThunderDome XBRL - 04:54PM UTC 2021-03-26 -->
<xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:navb="http://www.navidea.com/20201231" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.navidea.com/20201231">
<xsd:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2020-01-31" schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="navb-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="navb-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="navb-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="navb-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.navidea.com/20201231/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 000 - Document - Document And Entity Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-consolidated-balance-sheets" roleURI="http://www.navidea.com/20201231/role/statement-consolidated-balance-sheets">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 001 - Statement - Consolidated Balance Sheets </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-consolidated-balance-sheets-parentheticals" roleURI="http://www.navidea.com/20201231/role/statement-consolidated-balance-sheets-parentheticals">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 002 - Statement - Consolidated Balance Sheets (Parentheticals) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-consolidated-statements-of-operations" roleURI="http://www.navidea.com/20201231/role/statement-consolidated-statements-of-operations">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 003 - Statement - Consolidated Statements of Operations </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-consolidated-statements-of-comprehensive-loss" roleURI="http://www.navidea.com/20201231/role/statement-consolidated-statements-of-comprehensive-loss">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 004 - Statement - Consolidated Statements of Comprehensive Loss </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-consolidated-statements-of-stockholders-equity-deficit" roleURI="http://www.navidea.com/20201231/role/statement-consolidated-statements-of-stockholders-equity-deficit">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-consolidated-statements-of-stockholders-equity-deficit-parentheticals" roleURI="http://www.navidea.com/20201231/role/statement-consolidated-statements-of-stockholders-equity-deficit-parentheticals">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 006 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parentheticals) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-consolidated-statements-of-cash-flows" roleURI="http://www.navidea.com/20201231/role/statement-consolidated-statements-of-cash-flows">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 007 - Statement - Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies" roleURI="http://www.navidea.com/20201231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 008 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-liquidity" roleURI="http://www.navidea.com/20201231/role/statement-note-2-liquidity">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 009 - Disclosure - Note 2 - Liquidity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers" roleURI="http://www.navidea.com/20201231/role/statement-note-3-revenue-from-contracts-with-customers">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 010 - Disclosure - Note 3 - Revenue From Contracts With Customers </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-stockbased-compensation" roleURI="http://www.navidea.com/20201231/role/statement-note-4-stockbased-compensation">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 011 - Disclosure - Note 4 - Stock-based Compensation </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-loss-per-share" roleURI="http://www.navidea.com/20201231/role/statement-note-5-loss-per-share">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 012 - Disclosure - Note 5 - Loss Per Share </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk" roleURI="http://www.navidea.com/20201231/role/statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 013 - Disclosure - Note 6 - Stock Subscriptions and Other Receivables and Concentrations of Credit Risk </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-inventory" roleURI="http://www.navidea.com/20201231/role/statement-note-7-inventory">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 014 - Disclosure - Note 7 - Inventory </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-property-and-equipment" roleURI="http://www.navidea.com/20201231/role/statement-note-8-property-and-equipment">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 015 - Disclosure - Note 8 - Property and Equipment </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-9-investment-in-macrophage-therapeutics-inc" roleURI="http://www.navidea.com/20201231/role/statement-note-9-investment-in-macrophage-therapeutics-inc">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 016 - Disclosure - Note 9 - Investment in Macrophage Therapeutics, Inc. </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-10-accounts-payable-accrued-liabilities-and-other" roleURI="http://www.navidea.com/20201231/role/statement-note-10-accounts-payable-accrued-liabilities-and-other">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 017 - Disclosure - Note 10 - Accounts Payable, Accrued Liabilities and Other </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-11-notes-payable" roleURI="http://www.navidea.com/20201231/role/statement-note-11-notes-payable">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 018 - Disclosure - Note 11 - Notes Payable </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-leases" roleURI="http://www.navidea.com/20201231/role/statement-note-12-leases">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 019 - Disclosure - Note 12 - Leases </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-13-commitments-and-contingencies" roleURI="http://www.navidea.com/20201231/role/statement-note-13-commitments-and-contingencies">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 020 - Disclosure - Note 13 - Commitments and Contingencies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-equity-instruments" roleURI="http://www.navidea.com/20201231/role/statement-note-14-equity-instruments">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 021 - Disclosure - Note 14 - Equity Instruments </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-income-taxes" roleURI="http://www.navidea.com/20201231/role/statement-note-15-income-taxes">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 022 - Disclosure - Note 15 - Income Taxes </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-16-segments" roleURI="http://www.navidea.com/20201231/role/statement-note-16-segments">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 023 - Disclosure - Note 16 - Segments </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-17-material-agreements" roleURI="http://www.navidea.com/20201231/role/statement-note-17-material-agreements">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 024 - Disclosure - Note 17 - Material Agreements </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-18-employee-benefit-plan" roleURI="http://www.navidea.com/20201231/role/statement-note-18-employee-benefit-plan">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 025 - Disclosure - Note 18 - Employee Benefit Plan </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-19-supplemental-disclosure-for-statements-of-cash-flows" roleURI="http://www.navidea.com/20201231/role/statement-note-19-supplemental-disclosure-for-statements-of-cash-flows">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 026 - Disclosure - Note 19 - Supplemental Disclosure for Statements of Cash Flows </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-20-subsequent-events" roleURI="http://www.navidea.com/20201231/role/statement-note-20-subsequent-events">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 027 - Disclosure - Note 20 - Subsequent Events </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-significant-accounting-policies-policies" roleURI="http://www.navidea.com/20201231/role/statement-significant-accounting-policies-policies">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 028 - Disclosure - Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 029 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-3-revenue-from-contracts-with-customers-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 030 - Disclosure - Note 3 - Revenue From Contracts With Customers (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-stockbased-compensation-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-4-stockbased-compensation-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 031 - Disclosure - Note 4 - Stock-based Compensation (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 032 - Disclosure - Note 6 - Stock Subscriptions and Other Receivables and Concentrations of Credit Risk (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-inventory-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-7-inventory-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 033 - Disclosure - Note 7 - Inventory (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-property-and-equipment-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-8-property-and-equipment-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 034 - Disclosure - Note 8 - Property and Equipment (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-10-accounts-payable-accrued-liabilities-and-other-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-10-accounts-payable-accrued-liabilities-and-other-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 035 - Disclosure - Note 10 - Accounts Payable, Accrued Liabilities and Other (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-leases-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-12-leases-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 036 - Disclosure - Note 12 - Leases (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-equity-instruments-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-14-equity-instruments-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 037 - Disclosure - Note 14 - Equity Instruments (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-income-taxes-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-15-income-taxes-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 038 - Disclosure - Note 15 - Income Taxes (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-16-segments-tables" roleURI="http://www.navidea.com/20201231/role/statement-note-16-segments-tables">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 039 - Disclosure - Note 16 - Segments (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 040 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-1-organization-and-summary-of-significant-accounting-policies-assumptions-used-to-calculate-fair-value-of-stock-option-awards-granted-details" roleURI="http://www.navidea.com/20201231/role/statement-note-1-organization-and-summary-of-significant-accounting-policies-assumptions-used-to-calculate-fair-value-of-stock-option-awards-granted-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 041 - Disclosure - Note 1 - Organization and Summary of Significant Accounting Policies - Assumptions Used to Calculate Fair Value of Stock Option Awards Granted (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-2-liquidity-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-2-liquidity-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 042 - Disclosure - Note 2 - Liquidity (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-3-revenue-from-contracts-with-customers-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 043 - Disclosure - Note 3 - Revenue From Contracts With Customers (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details" roleURI="http://www.navidea.com/20201231/role/statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 044 - Disclosure - Note 3 - Revenue From Contracts With Customers - Disaggregation of Revenue (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-3-revenue-from-contracts-with-customers-changes-in-contract-liabilities-details" roleURI="http://www.navidea.com/20201231/role/statement-note-3-revenue-from-contracts-with-customers-changes-in-contract-liabilities-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 045 - Disclosure - Note 3 - Revenue From Contracts With Customers - Changes in Contract Liabilities (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-stockbased-compensation-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-4-stockbased-compensation-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 046 - Disclosure - Note 4 - Stock-based Compensation (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-stockbased-compensation-summary-of-stock-option-activity-details" roleURI="http://www.navidea.com/20201231/role/statement-note-4-stockbased-compensation-summary-of-stock-option-activity-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 047 - Disclosure - Note 4 - Stock-based Compensation - Summary of Stock Option Activity (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-4-stockbased-compensation-summary-of-unvested-restricted-stock-details" roleURI="http://www.navidea.com/20201231/role/statement-note-4-stockbased-compensation-summary-of-unvested-restricted-stock-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 048 - Disclosure - Note 4 - Stock-based Compensation - Summary of Unvested Restricted Stock (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-5-loss-per-share-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-5-loss-per-share-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 049 - Disclosure - Note 5 - Loss Per Share (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 050 - Disclosure - Note 6 - Stock Subscriptions and Other Receivables and Concentrations of Credit Risk (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-accounts-and-other-receivables-details" roleURI="http://www.navidea.com/20201231/role/statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-accounts-and-other-receivables-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 051 - Disclosure - Note 6 - Stock Subscriptions and Other Receivables and Concentrations of Credit Risk - Accounts and Other Receivables (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-inventory-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-7-inventory-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 052 - Disclosure - Note 7 - Inventory (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-7-inventory-net-inventory-details" roleURI="http://www.navidea.com/20201231/role/statement-note-7-inventory-net-inventory-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 053 - Disclosure - Note 7 - Inventory - Net Inventory (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-property-and-equipment-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-8-property-and-equipment-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 054 - Disclosure - Note 8 - Property and Equipment (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-8-property-and-equipment-summary-of-major-classes-of-property-and-equipment-details" roleURI="http://www.navidea.com/20201231/role/statement-note-8-property-and-equipment-summary-of-major-classes-of-property-and-equipment-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 055 - Disclosure - Note 8 - Property and Equipment - Summary of Major Classes of Property and Equipment (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-9-investment-in-macrophage-therapeutics-inc-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-9-investment-in-macrophage-therapeutics-inc-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 056 - Disclosure - Note 9 - Investment in Macrophage Therapeutics, Inc. (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-10-accounts-payable-accrued-liabilities-and-other-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-10-accounts-payable-accrued-liabilities-and-other-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 057 - Disclosure - Note 10 - Accounts Payable, Accrued Liabilities and Other (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-10-accounts-payable-accrued-liabilities-and-other-accrued-liabilities-and-other-details" roleURI="http://www.navidea.com/20201231/role/statement-note-10-accounts-payable-accrued-liabilities-and-other-accrued-liabilities-and-other-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 058 - Disclosure - Note 10 - Accounts Payable, Accrued Liabilities and Other - Accrued Liabilities and Other (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-11-notes-payable-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-11-notes-payable-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 059 - Disclosure - Note 11 - Notes Payable (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-leases-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-12-leases-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 060 - Disclosure - Note 12 - Leases (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-leases-impact-of-the-adoption-of-asu-201602-on-our-balance-sheet-details" roleURI="http://www.navidea.com/20201231/role/statement-note-12-leases-impact-of-the-adoption-of-asu-201602-on-our-balance-sheet-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 061 - Disclosure - Note 12 - Leases - Impact of the Adoption of ASU 2016-02 on Our Balance Sheet (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-leases-maturity-of-lease-liabilities-details" roleURI="http://www.navidea.com/20201231/role/statement-note-12-leases-maturity-of-lease-liabilities-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 062 - Disclosure - Note 12 - Leases - Maturity of Lease Liabilities (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-leases-balance-sheet-classification-details" roleURI="http://www.navidea.com/20201231/role/statement-note-12-leases-balance-sheet-classification-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 063 - Disclosure - Note 12 - Leases - Balance Sheet Classification (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-12-leases-other-information-details" roleURI="http://www.navidea.com/20201231/role/statement-note-12-leases-other-information-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 064 - Disclosure - Note 12 - Leases - Other Information (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-13-commitments-and-contingencies-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-13-commitments-and-contingencies-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 065 - Disclosure - Note 13 - Commitments and Contingencies (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-equity-instruments-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-14-equity-instruments-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 066 - Disclosure - Note 14 - Equity Instruments (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-14-equity-instruments-outstanding-warrants-details" roleURI="http://www.navidea.com/20201231/role/statement-note-14-equity-instruments-outstanding-warrants-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 067 - Disclosure - Note 14 - Equity Instruments - Outstanding Warrants (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-income-taxes-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-15-income-taxes-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 068 - Disclosure - Note 15 - Income Taxes (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-income-taxes-components-of-deferred-tax-assets-details" roleURI="http://www.navidea.com/20201231/role/statement-note-15-income-taxes-components-of-deferred-tax-assets-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 069 - Disclosure - Note 15 - Income Taxes - Components of Deferred Tax Assets (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-income-taxes-net-operating-loss-and-credit-carryforwards-details" roleURI="http://www.navidea.com/20201231/role/statement-note-15-income-taxes-net-operating-loss-and-credit-carryforwards-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 070 - Disclosure - Note 15 - Income Taxes - Net Operating Loss and Credit Carryforwards (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-15-income-taxes-reconciliations-between-the-statutory-federal-income-tax-rate-and-the-effective-tax-rate-details" roleURI="http://www.navidea.com/20201231/role/statement-note-15-income-taxes-reconciliations-between-the-statutory-federal-income-tax-rate-and-the-effective-tax-rate-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 071 - Disclosure - Note 15 - Income Taxes - Reconciliations Between the Statutory Federal Income Tax Rate and the Effective Tax Rate (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-16-segments-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-16-segments-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 072 - Disclosure - Note 16 - Segments (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-16-segments-segment-information-details" roleURI="http://www.navidea.com/20201231/role/statement-note-16-segments-segment-information-details">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 073 - Disclosure - Note 16 - Segments - Segment Information (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-17-material-agreements-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-17-material-agreements-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 074 - Disclosure - Note 17 - Material Agreements (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-18-employee-benefit-plan-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-18-employee-benefit-plan-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 075 - Disclosure - Note 18 - Employee Benefit Plan (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-19-supplemental-disclosure-for-statements-of-cash-flows-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-19-supplemental-disclosure-for-statements-of-cash-flows-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 076 - Disclosure - Note 19 - Supplemental Disclosure for Statements of Cash Flows (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
<link:roleType id="statement-note-20-subsequent-events-details-textual" roleURI="http://www.navidea.com/20201231/role/statement-note-20-subsequent-events-details-textual">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase"> 077 - Disclosure - Note 20 - Subsequent Events (Details Textual) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="navb_AccountsAndOtherReceivablesMember" name="AccountsAndOtherReceivablesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_AccountsPayable1Member" name="AccountsPayable1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_AccruedLiabilitiesAndOtherMember" name="AccruedLiabilitiesAndOtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_AccruedLiabilitiesContractedServicesCurrent" name="AccruedLiabilitiesContractedServicesCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_AdjustmentsToAdditionalPaidInCapitalDeemedDividends" name="AdjustmentsToAdditionalPaidInCapitalDeemedDividends" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_AdjustmentsToStockReverseStockSplit" name="AdjustmentsToStockReverseStockSplit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_AlternativeMinimumTaxMember" name="AlternativeMinimumTaxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_AmendedAndRestatedTilmanoceptLicenseAgreementMember" name="AmendedAndRestatedTilmanoceptLicenseAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_AnInvestorMember" name="AnInvestorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_BeforeReverseStockSplitMember" name="BeforeReverseStockSplitMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_CRGLoanAgreementOhioCaseMember" name="CRGLoanAgreementOhioCaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_CRGLoanAgreementTexasCaseMember" name="CRGLoanAgreementTexasCaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_CRGMember" name="CRGMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ChangeInEstimatedFairValueOfWarrants" name="ChangeInEstimatedFairValueOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_ClassOfWarrantOrRightExercisedDuringPeriod" name="ClassOfWarrantOrRightExercisedDuringPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ClassOfWarrantOrRightExpirationDate" name="ClassOfWarrantOrRightExpirationDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:dateItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ClassOfWarrantOrRightGrantsInPeriodEstimatedFairValue" name="ClassOfWarrantOrRightGrantsInPeriodEstimatedFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_ClassOfWarrantOrRightPercentOfCommonStockSold" name="ClassOfWarrantOrRightPercentOfCommonStockSold" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_ClearingExpensesMember" name="ClearingExpensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_ClinicalTrialsMember" name="ClinicalTrialsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_CommissionToUnderwriterPercentageOfGrossProceeds" name="CommissionToUnderwriterPercentageOfGrossProceeds" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_CommonStockAsPercentageOfCommonEquity" name="CommonStockAsPercentageOfCommonEquity" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_CommonStockCalledByWarrantsAsPercentageOfCommonStockSold" name="CommonStockCalledByWarrantsAsPercentageOfCommonStockSold" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_CommonStockIssuanceCostsMember" name="CommonStockIssuanceCostsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_CommonStockSharesAuthorizedUponExerciseOfWarrants" name="CommonStockSharesAuthorizedUponExerciseOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_CommonStockSharesProvidedByAgreement" name="CommonStockSharesProvidedByAgreement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_CommonStockSharesProvidedByAgreementEscrowPeriod" name="CommonStockSharesProvidedByAgreementEscrowPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_CommonStockSubscriptionMember" name="CommonStockSubscriptionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_CommonStockSubscriptionsReceivableMember" name="CommonStockSubscriptionsReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_CommonStockWarrantsIssuedUponConversionPerUnit" name="CommonStockWarrantsIssuedUponConversionPerUnit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ContractWithCustomerAssetImpairmentLoss" name="ContractWithCustomerAssetImpairmentLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_ContractWithCustomerLiabilityRefundOfRevenueDeferredRelatedToSublicense" name="ContractWithCustomerLiabilityRefundOfRevenueDeferredRelatedToSublicense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_ContractWithCustomerLiabilityRevenueDeferredRelatedToSublicense" name="ContractWithCustomerLiabilityRevenueDeferredRelatedToSublicense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_ContractWithCustomerPaymentTermMaximum" name="ContractWithCustomerPaymentTermMaximum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ContractWithCustomerPaymentTermMinimum" name="ContractWithCustomerPaymentTermMinimum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ContractWithCustomerTermOfContract" name="ContractWithCustomerTermOfContract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ContractWithCustomerTransactionPriceOfRoyaltiesUsingExpectedValueMethod" name="ContractWithCustomerTransactionPriceOfRoyaltiesUsingExpectedValueMethod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_ConversionFromSeriesCPreferredStockToCommonStockMember" name="ConversionFromSeriesCPreferredStockToCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_ConversionFromSeriesDPreferredStockToCommonStockMember" name="ConversionFromSeriesDPreferredStockToCommonStockMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ConvertiblePreferredStockConversionPriceMarketCap" name="ConvertiblePreferredStockConversionPriceMarketCap" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_ConvertiblePreferredStockDiscountToMarketRate" name="ConvertiblePreferredStockDiscountToMarketRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_ConvertiblePreferredStockMaximumAllowedPercentageOfCommonStockOutstandingUsedInConversionShares" name="ConvertiblePreferredStockMaximumAllowedPercentageOfCommonStockOutstandingUsedInConversionShares" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_ConvertiblePreferredStockPIKCouponPercentage" name="ConvertiblePreferredStockPIKCouponPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_ConvertiblePreferredStockPercentOfSharesReserved" name="ConvertiblePreferredStockPercentOfSharesReserved" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_ConvertiblePreferredStockSharesIssuedUponConversionPerUnit" name="ConvertiblePreferredStockSharesIssuedUponConversionPerUnit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_DebtInstrumentAgreedUponFinalPayoffAmountLowPayoffAmount" name="DebtInstrumentAgreedUponFinalPayoffAmountLowPayoffAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_DeferredTaxAssetsDisallowedInterestExpense" name="DeferredTaxAssetsDisallowedInterestExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="navb_DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment" name="DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="navb_DeferredTaxAssetsTemporaryDifference" name="DeferredTaxAssetsTemporaryDifference" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_DiagnosticsSegmentMember" name="DiagnosticsSegmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_DirectorFeesMember" name="DirectorFeesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_DrMichaelGoldbergMember" name="DrMichaelGoldbergMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_DrawsOnLetterOfCredit" name="DrawsOnLetterOfCredit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_EmployeesMember" name="EmployeesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_EmploymentAgreementMember" name="EmploymentAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_ExpandedTc99mTilmanoceptLicenseAgreementMember" name="ExpandedTc99mTilmanoceptLicenseAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_FeesAndExpensesOfLegalCounselMember" name="FeesAndExpensesOfLegalCounselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_FifMember" name="FifMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ForgivenessOfNotesPayable" name="ForgivenessOfNotesPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_FormerChiefExecutiveOfficerAndPresidentMember" name="FormerChiefExecutiveOfficerAndPresidentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_FutureCommonStockConversionDenominatorValue" name="FutureCommonStockConversionDenominatorValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_FutureCommonStockConversionSharePrice" name="FutureCommonStockConversionSharePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_GrantAndOtherRevenue" name="GrantAndOtherRevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_GrantRevenueReceivableMember" name="GrantRevenueReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_IPFSMember" name="IPFSMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_IncreaseDecreaseInLeaseLiabilities" name="IncreaseDecreaseInLeaseLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_IncreaseDecreaseInStockSubscriptionAndOtherReceivables" name="IncreaseDecreaseInStockSubscriptionAndOtherReceivables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_IssuanceOfStockAndWarrantsForPurchaseAgreementRemainingAmount" name="IssuanceOfStockAndWarrantsForPurchaseAgreementRemainingAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_IssuanceOfStockToDefinedContributionPlanForEmployerMatchingContribution" name="IssuanceOfStockToDefinedContributionPlanForEmployerMatchingContribution" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_IssuedStockUponExerciseOfWarrantsShares" name="IssuedStockUponExerciseOfWarrantsShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_JohnKScottJrMember" name="JohnKScottJrMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_JubilantMember" name="JubilantMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_KeystoneCapitalPartnersLLCMember" name="KeystoneCapitalPartnersLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_LesseeOperatingLeaseAssetsAndLiabilitiesTableTextBlock" name="LesseeOperatingLeaseAssetsAndLiabilitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_LicenseIssueFee" name="LicenseIssueFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_LicenseMaintenanceFee" name="LicenseMaintenanceFee" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_LicenseRevenueReceivableMember" name="LicenseRevenueReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_LitigationSettlementReversalOfAmountAwardedFromOtherParty" name="LitigationSettlementReversalOfAmountAwardedFromOtherParty" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_LongTermContractForSuppliesOptionToExtendTerm" name="LongTermContractForSuppliesOptionToExtendTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_LossContingencyDamagesAwardedValueAdditionalAmount" name="LossContingencyDamagesAwardedValueAdditionalAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_LossContingencyDamagesAwardedValueAmountNotTakenIntoConsideration" name="LossContingencyDamagesAwardedValueAmountNotTakenIntoConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_MTMember" name="MTMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_MacrophageTherapeuticsMember" name="MacrophageTherapeuticsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_MarketCapitalizationFairValue" name="MarketCapitalizationFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_MastiffGroupLLCMember" name="MastiffGroupLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_MinimumAnnualRoyalty" name="MinimumAnnualRoyalty" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_NatureOfOperationsPolicyTextBlock" name="NatureOfOperationsPolicyTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_Nav4694SublicenseMember" name="Nav4694SublicenseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_NavideaBiopharmaceuticalsLimitedMember" name="NavideaBiopharmaceuticalsLimitedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_NavideaEuropeMember" name="NavideaEuropeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_NonaccountableExpensesMember" name="NonaccountableExpensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_NoncashLeaseExpense" name="NoncashLeaseExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_NonoperatingIncomeExpenseIncludingEquityMethodInvestments" name="NonoperatingIncomeExpenseIncludingEquityMethodInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_NoteToFinancialStatementDetailsTextual" name="NoteToFinancialStatementDetailsTextual" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_NotesPayableIssuedForPrepaymentOfInsurancePremiumsMember" name="NotesPayableIssuedForPrepaymentOfInsurancePremiumsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_NotesToFinancialStatements" name="NotesToFinancialStatements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_NumberOfPrimaryTypesOfProductsSold" name="NumberOfPrimaryTypesOfProductsSold" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_OfferingInvestorMember" name="OfferingInvestorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_OfficeLeaseMember" name="OfficeLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_OfficeSpaceAt4995BradentonAvenueDublinOhioMember" name="OfficeSpaceAt4995BradentonAvenueDublinOhioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_OfficeSpaceAt5600BlazerParkwayDublinOhioMember" name="OfficeSpaceAt5600BlazerParkwayDublinOhioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_OfficeSpaceAt560SylvanAvenueEnglewoodCliffsNewJerseyMember" name="OfficeSpaceAt560SylvanAvenueEnglewoodCliffsNewJerseyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_OhioCourtOfCommonPleasMember" name="OhioCourtOfCommonPleasMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_OperatingLeaseMonthlyBaseRent" name="OperatingLeaseMonthlyBaseRent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_OperatingLeaseRightofuseAssetGross" name="OperatingLeaseRightofuseAssetGross" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="navb_OperatingLeaseRightofuseAssetsAccumulatedAmortization" name="OperatingLeaseRightofuseAssetsAccumulatedAmortization" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_OperatingLeaseSubleaseMonthlyRentRevenue" name="OperatingLeaseSubleaseMonthlyRentRevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_OperatingLossCarryforwardsStockBasedCompensation" name="OperatingLossCarryforwardsStockBasedCompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_OtherAccountsReceivableMember" name="OtherAccountsReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_OutsideTheTerritoryMember" name="OutsideTheTerritoryMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_OwnershipPercentage" name="OwnershipPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_PatentAndTrademarkCosts" name="PatentAndTrademarkCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_PaycheckProtectionProgramCaresActMember" name="PaycheckProtectionProgramCaresActMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_PercentOfOfferingPriceToPublicPerShare" name="PercentOfOfferingPriceToPublicPerShare" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_PlatinumMember" name="PlatinumMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_PlatinumMontaurLifeSciencesLLCLitigationMember" name="PlatinumMontaurLifeSciencesLLCLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_PreferredConvertibleStockRightToExchangeForCommonSharesMinimumRequiredProceedsFromInitialPublicOffering" name="PreferredConvertibleStockRightToExchangeForCommonSharesMinimumRequiredProceedsFromInitialPublicOffering" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_PreferredStockDeemedDividend" name="PreferredStockDeemedDividend" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_PreferredStockFairValuePutOption" name="PreferredStockFairValuePutOption" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_PreferredStockIssuanceCostsMember" name="PreferredStockIssuanceCostsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_PreferredStockSubscriptionMember" name="PreferredStockSubscriptionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_PreferredStockSubscriptionsReceivableMember" name="PreferredStockSubscriptionsReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_PreviouslyCapitalizedPatentCostsAbandoned" name="PreviouslyCapitalizedPatentCostsAbandoned" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="navb_ProceedsFromSaleOfPaymentsToAcquirePropertyPlantAndEquipment" name="ProceedsFromSaleOfPaymentsToAcquirePropertyPlantAndEquipment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_ProcessDevelopmentMember" name="ProcessDevelopmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_PurchasedSoftwareMember" name="PurchasedSoftwareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ReclassificationOfFundsInvested" name="ReclassificationOfFundsInvested" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_ReliableSupplyAgreementMember" name="ReliableSupplyAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ResignationAgreementSharesInEscrow" name="ResignationAgreementSharesInEscrow" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_ResignationAgreementSharesIssued" name="ResignationAgreementSharesIssued" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ResignationAgreementSubsidiaryPercentageOwnershipAfterSigning" name="ResignationAgreementSubsidiaryPercentageOwnershipAfterSigning" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_RevaluationOfDeferredTaxAssetDecrease" name="RevaluationOfDeferredTaxAssetDecrease" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_ReverseStockSplitMember" name="ReverseStockSplitMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_SaleOfStockAdditionalMilestoneCommitmentAmount" name="SaleOfStockAdditionalMilestoneCommitmentAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_SaleOfStockCommitmentAmount" name="SaleOfStockCommitmentAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_SellingGeneralAndAdministrativeExpenseExcludingDepreciationAndAmortization" name="SellingGeneralAndAdministrativeExpenseExcludingDepreciationAndAmortization" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_SeriesHHWarrantsMember" name="SeriesHHWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_SeriesKkWarrantsMember" name="SeriesKkWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_SeriesLLWarrantsMember" name="SeriesLLWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_SeriesNNWarrantsMember" name="SeriesNNWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_SeriesOOWarrantsMember" name="SeriesOOWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRateMaximum" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRateMaximum" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRateMinimum" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRateMinimum" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_SignificantAgreementsDisclosureTextBlock" name="SignificantAgreementsDisclosureTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedDuringPeriodInPaymentOfFeesShares" name="StockIssuedDuringPeriodInPaymentOfFeesShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedDuringPeriodInPaymentOfFeesStockValue" name="StockIssuedDuringPeriodInPaymentOfFeesStockValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedDuringPeriodSharesIssuedForEmployeeBonuses" name="StockIssuedDuringPeriodSharesIssuedForEmployeeBonuses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedDuringPeriodSharesNewIssuesPlacedInEscrow" name="StockIssuedDuringPeriodSharesNewIssuesPlacedInEscrow" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedDuringPeriodValueIssuedForEmployeeBonuses" name="StockIssuedDuringPeriodValueIssuedForEmployeeBonuses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedDuringPeriodValueIssuedUponExerciseOfWarrants" name="StockIssuedDuringPeriodValueIssuedUponExerciseOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedDuringPeriodValueMou" name="StockIssuedDuringPeriodValueMou" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_StockIssuedManagementFeePercentage" name="StockIssuedManagementFeePercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_StockOptionsAndWarrantsMember" name="StockOptionsAndWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_StockPurchaseAgreementMaximumValue" name="StockPurchaseAgreementMaximumValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="navb_StockSubscribedDuringPeriodShares" name="StockSubscribedDuringPeriodShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_StockSubscribedDuringPeriodValue" name="StockSubscribedDuringPeriodValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_StockSubscriptionsAndOtherReceivables" name="StockSubscriptionsAndOtherReceivables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_StockSubscriptionsMember" name="StockSubscriptionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_StockSubscriptionsReceivable" name="StockSubscriptionsReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="navb_TaxCreditCarryforwardAmountExpiredDuringPeriod" name="TaxCreditCarryforwardAmountExpiredDuringPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="navb_TaxCreditCarryforwardsAlternativeMinimumTaxPercentageIncludedInOtherNoncurrentAssets" name="TaxCreditCarryforwardsAlternativeMinimumTaxPercentageIncludedInOtherNoncurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element id="navb_TaxCreditCarryforwardsAlternativeMinimumTaxPercentageIncludedInPrepaidAndOtherCurrentAssets" name="TaxCreditCarryforwardsAlternativeMinimumTaxPercentageIncludedInPrepaidAndOtherCurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_TaxYear2001Member" name="TaxYear2001Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_TaxYear2002Member" name="TaxYear2002Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_TaxYear2003Member" name="TaxYear2003Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_TaxYear2004Member" name="TaxYear2004Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_TaxYear2005Member" name="TaxYear2005Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_Tc99mTilmanoceptLicenseAgreementMember" name="Tc99mTilmanoceptLicenseAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_TermLoanAgreementMember" name="TermLoanAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_TerminatedLeaseLiability" name="TerminatedLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="navb_The2002And2014PlanMember" name="The2002And2014PlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_The2014PlanMember" name="The2014PlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_TherapeuticsSegmentMember" name="TherapeuticsSegmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_TilmanoceptLicenseAgreementMember" name="TilmanoceptLicenseAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_UnderwriterMember" name="UnderwriterMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_UnderwriterWarrantsMember" name="UnderwriterWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_UnderwritingAgreementWarrantsMember" name="UnderwritingAgreementWarrantsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_UnderwrittenPublicOfferingMember" name="UnderwrittenPublicOfferingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_ValueOfStockIssuedToEmployees" name="ValueOfStockIssuedToEmployees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_VehicleLeaseMember" name="VehicleLeaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_VestingAsScheduledMember" name="VestingAsScheduledMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="navb_WeightedAveragePriceCommonStockPercentage" name="WeightedAveragePriceCommonStockPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-assumptions-used-to-calculate-fair-value-of-stock-option-awards-granted-details" name="statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-assumptions-used-to-calculate-fair-value-of-stock-option-awards-granted-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" name="statement-statement-note-1-organization-and-summary-of-significant-accounting-policies-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-10-accounts-payable-accrued-liabilities-and-other-accrued-liabilities-and-other-details" name="statement-statement-note-10-accounts-payable-accrued-liabilities-and-other-accrued-liabilities-and-other-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-10-accounts-payable-accrued-liabilities-and-other-tables" name="statement-statement-note-10-accounts-payable-accrued-liabilities-and-other-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-12-leases-balance-sheet-classification-details" name="statement-statement-note-12-leases-balance-sheet-classification-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-12-leases-impact-of-the-adoption-of-asu-201602-on-our-balance-sheet-details" name="statement-statement-note-12-leases-impact-of-the-adoption-of-asu-201602-on-our-balance-sheet-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-12-leases-maturity-of-lease-liabilities-details" name="statement-statement-note-12-leases-maturity-of-lease-liabilities-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-12-leases-other-information-details" name="statement-statement-note-12-leases-other-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-12-leases-tables" name="statement-statement-note-12-leases-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-14-equity-instruments-outstanding-warrants-details" name="statement-statement-note-14-equity-instruments-outstanding-warrants-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-14-equity-instruments-tables" name="statement-statement-note-14-equity-instruments-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-15-income-taxes-components-of-deferred-tax-assets-details" name="statement-statement-note-15-income-taxes-components-of-deferred-tax-assets-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-15-income-taxes-net-operating-loss-and-credit-carryforwards-details" name="statement-statement-note-15-income-taxes-net-operating-loss-and-credit-carryforwards-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-15-income-taxes-reconciliations-between-the-statutory-federal-income-tax-rate-and-the-effective-tax-rate-details" name="statement-statement-note-15-income-taxes-reconciliations-between-the-statutory-federal-income-tax-rate-and-the-effective-tax-rate-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-15-income-taxes-tables" name="statement-statement-note-15-income-taxes-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-16-segments-segment-information-details" name="statement-statement-note-16-segments-segment-information-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-16-segments-tables" name="statement-statement-note-16-segments-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-3-revenue-from-contracts-with-customers-changes-in-contract-liabilities-details" name="statement-statement-note-3-revenue-from-contracts-with-customers-changes-in-contract-liabilities-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details" name="statement-statement-note-3-revenue-from-contracts-with-customers-disaggregation-of-revenue-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-3-revenue-from-contracts-with-customers-tables" name="statement-statement-note-3-revenue-from-contracts-with-customers-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-4-stockbased-compensation-summary-of-stock-option-activity-details" name="statement-statement-note-4-stockbased-compensation-summary-of-stock-option-activity-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-4-stockbased-compensation-summary-of-unvested-restricted-stock-details" name="statement-statement-note-4-stockbased-compensation-summary-of-unvested-restricted-stock-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-4-stockbased-compensation-tables" name="statement-statement-note-4-stockbased-compensation-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-accounts-and-other-receivables-details" name="statement-statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-accounts-and-other-receivables-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-tables" name="statement-statement-note-6-stock-subscriptions-and-other-receivables-and-concentrations-of-credit-risk-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-7-inventory-net-inventory-details" name="statement-statement-note-7-inventory-net-inventory-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-7-inventory-tables" name="statement-statement-note-7-inventory-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-8-property-and-equipment-summary-of-major-classes-of-property-and-equipment-details" name="statement-statement-note-8-property-and-equipment-summary-of-major-classes-of-property-and-equipment-details" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-note-8-property-and-equipment-tables" name="statement-statement-note-8-property-and-equipment-tables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="navb_statement-statement-significant-accounting-policies-policies" name="statement-statement-significant-accounting-policies-policies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/22  Navidea Biopharmaceuticals, Inc.  S-1         2/11/22    3:944K                                   RDG Filings/FA
 5/24/21  Navidea Biopharmaceuticals, Inc.  424B3                  1:190K                                   RDG Filings/FA
 5/13/21  Navidea Biopharmaceuticals, Inc.  S-1                    3:378K                                   RDG Filings/FA

33 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/21  Navidea Biopharmaceuticals, Inc.  8-K:1,3,5,9 3/02/21    5:363K                                   RDG Filings/FA
 2/08/21  Navidea Biopharmaceuticals, Inc.  S-3                    4:908K                                   RDG Filings/FA
11/13/20  Navidea Biopharmaceuticals, Inc.  S-8        11/13/20    4:1.7M                                   RDG Filings/FA
 9/02/20  Navidea Biopharmaceuticals, Inc.  8-K:1,5,9   8/28/20    6:435K                                   RDG Filings/FA
 8/25/20  Navidea Biopharmaceuticals, Inc.  S-3                    4:401K                                   RDG Filings/FA
 8/14/20  Navidea Biopharmaceuticals, Inc.  10-Q        6/30/20   65:6.4M                                   RDG Filings/FA
 7/31/20  Navidea Biopharmaceuticals, Inc.  8-K:5,9     7/27/20    2:123K                                   RDG Filings/FA
 5/12/20  Navidea Biopharmaceuticals, Inc.  8-K:1,3,5,9 5/06/20    5:347K                                   RDG Filings/FA
 3/18/20  Navidea Biopharmaceuticals, Inc.  10-K       12/31/19   97:10M                                    RDG Filings/FA
12/31/19  Navidea Biopharmaceuticals, Inc.  S-3                    4:979K                                   RDG Filings/FA
12/11/19  Navidea Biopharmaceuticals, Inc.  8-K:1,3,9  12/06/19    4:270K                                   RDG Filings/FA
 6/17/19  Navidea Biopharmaceuticals, Inc.  8-K:1,3,8,9 6/13/19    7:521K                                   RDG Filings/FA
 4/26/19  Navidea Biopharmaceuticals, Inc.  8-K:3,5,9   4/26/19    2:30K                                    RDG Filings/FA
11/09/18  Navidea Biopharmaceuticals, Inc.  10-Q        9/30/18   72:7.1M                                   RDG Filings/FA
10/05/18  Navidea Biopharmaceuticals, Inc.  8-K:5,9    10/01/18    2:95K                                    RDG Filings/FA
 5/09/18  Navidea Biopharmaceuticals, Inc.  10-Q        3/31/18   74:6M                                     RDG Filings/FA
 3/31/17  Navidea Biopharmaceuticals, Inc.  10-K       12/31/16   96:7.9M                                   Blueprint/FA
 3/09/17  Navidea Biopharmaceuticals, Inc.  8-K:1,2,3,9 3/03/17    6:575K                                   Toppan Merrill/FA
11/30/16  Navidea Biopharmaceuticals, Inc.  8-K:1,9    11/23/16    3:857K                                   Toppan Merrill/FA
 5/10/16  Navidea Biopharmaceuticals, Inc.  8-K:5,9     5/04/16    2:60K                                    Toppan Merrill/FA
 1/11/16  Navidea Biopharmaceuticals, Inc.  8-K:1,8,9   1/06/16    4:271K                                   Toppan Merrill/FA
10/09/15  Navidea Biopharmaceuticals, Inc.  8-K/A:9     5/11/15    2:673K                                   Toppan Merrill/FA
 8/26/15  Navidea Biopharmaceuticals, Inc.  8-K:1,8,9   8/20/15    4:233K                                   Toppan Merrill/FA
 5/15/15  Navidea Biopharmaceuticals, Inc.  8-K:1,2,8,9 5/11/15    7:562K                                   Toppan Merrill/FA
 5/11/15  Navidea Biopharmaceuticals, Inc.  10-Q        3/31/15   66:5M
11/10/14  Navidea Biopharmaceuticals, Inc.  10-Q        9/30/14   60:4.3M
 8/11/14  Navidea Biopharmaceuticals, Inc.  10-Q        6/30/14   62:4.5M
 3/07/14  Navidea Biopharmaceuticals, Inc.  8-K:1,2,3,7 3/04/14    9:858K                                   Toppan Merrill/FA
11/12/13  Navidea Biopharmaceuticals, Inc.  10-Q        9/30/13   54:4.4M                                   Workiva Inc.
 9/05/13  Navidea Biopharmaceuticals, Inc.  8-K:1,8,9   8/29/13    3:459K                                   Toppan Merrill/FA
 6/28/13  Navidea Biopharmaceuticals, Inc.  8-K/A:1,2,3 6/24/13    8:1M                                     Toppan Merrill/FA
 6/26/13  Navidea Biopharmaceuticals, Inc.  8-K:1,2,3,5 6/24/13    4:177K                                   Toppan Merrill/FA
 4/11/12  Navidea Biopharmaceuticals, Inc.  8-K/A:1,5,812/09/11    2:476K                                   Toppan Merrill/FA
↑Top
Filing Submission 0001437749-21-007329   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 11:31:17.4pm ET